Physician profile
Camille Simbert
NPI 1033587472
$583.25
in general payments reported to CMS, 2019-2025
9 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $264 · 2022: $99.82 · 2023: $14.04 · 2024: $17.72 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $205.45 | 2021-2023 | |
| Exeltis, USA INC. | $92.12 | 2024-2025 | Slynd |
| Evofem Biosciences, INC. | $73.02 | 2021-2022 | |
| Agile Therapeutics, INC. | $65.76 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $53.64 | 2025 | |
| Ethicon US, LLC | $41.90 | 2025 | Enseal |
| Dysis Medical, INC. | $18.52 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.93 | 2025 | Menopur |
| Myovant Sciences INC. | $14.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Camille Simbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.